In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs
In Brief: McDonald, Coolidge Lead ACS; Medals Awarded To Rosenberg, Boutwell, LeMaistre
FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism
Patient Satisfaction Was Crucial In ODAC Review Of Panretin
NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery